RecruitingEarly Phase 1NCT06138236
Plantar Fascitiis: Comparison of ESWT and Collagen Hydrolyzed Peptides
Comparison of ESWT and Collagen Hydrolyzed Peptides in the Treatment of Plantar Fascitiis
Sponsor
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
Enrollment
84 participants
Start Date
Jul 1, 2023
Study Type
INTERVENTIONAL
Conditions
Summary
Patients suffering from Plantar Fasciitis were randomized into three groups: the first group underwent infiltration of Collagen Hydrolyzed Peptides, the second one underwent the ESWT treatment, the third one underwent a combination of the two treatments.
Eligibility
Min Age: 18 YearsMax Age: 80 Years
Inclusion Criteria1
- Plantar fascitiis Aged between 18 and 80 years old
Exclusion Criteria2
- Previous surgery of the foot
- Contraindications to ESWT
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGCollagen hydrolyzed peptides
infiltration near the heal spur of 2ml of Arthrys
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06138236
Related Trials
SakuraBead Used as Resorbable Embolic for Plantar Fascia Embolization
NCT072418841 location
Plantar Fasciitis Randomized Clinical Control Trial
NCT032311501 location
This is a Study to Evaluate a Pre-confectioned Plantar Insole for the Treatment of Plantar Heel Pain
NCT063864061 location
Dynamic Versus Static Night Splinting of Plantar Fasciitis
NCT054328952 locations
Treatment of Gastrocnemius Tightness and Subsequent Chronic Plantar Fasciitis with Botulinum Toxin a
NCT052187851 location